KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Acquisitions & Divestments (2017 - 2025)

Guardant Health's Change in Acquisitions & Divestments history spans 9 years, with the latest figure at $307.3 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $307.3 million; the TTM value through Dec 2025 reached $307.3 million, up 778.07%, while the annual FY2025 figure was $307.3 million, 778.07% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $307.3 million at Guardant Health, up from -$307.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $1.5 billion in Q4 2023 and bottomed at -$492.7 million in Q3 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $211.5 million (2021), against an average of $174.3 million.
  • The largest YoY upside for Change in Acquisitions & Divestments was 958.8% in 2023 against a maximum downside of 882.06% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $325.0 million in 2021, then crashed by 222.46% to -$398.0 million in 2022, then surged by 475.55% to $1.5 billion in 2023, then tumbled by 97.66% to $35.0 million in 2024, then skyrocketed by 778.07% to $307.3 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Change in Acquisitions & Divestments are $307.3 million (Q4 2025), -$307.3 million (Q3 2025), and $307.3 million (Q1 2025).